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Sir—We read with interest the paper of Alm et al. (2009). The 
authors looked at post- total hip arhtroplasty periprosthetic 
(THA) bone changes in 39 subjects using DXA to analyse 
bone mineral density (BMD) in the Gruen zones surrounding 
the femoral prosthesis component. The purpose of the study 
was to look for factors such as bone mineral status that might 
influence femoral periprosthetic bone loss.
 In Figure 4 of their paper, the authors graphed the change in 
BMD in Gruen zone 7 at 2 years post-THA expressed as a per-
centage of baseline BMD at that site (y-axis) against the lowest 
preoperative T score from lumbar spine, proximal femur or 
non-dominant  distal  forearm  (x-axis).  From  the  significant 
positive correlation they obtained between these graphed vari-
ables, they concluded that”low preoperative systemic BMD 
was associated with higher bone loss in Gruen zone 7”. 
We would like to introduce a note of caution here because 
we will show that it is possible to demonstrate a significant 
correlation between the variables as defined by Alm et al when 
there is absolutely no influence of systemic BMD on postop-
erative BMD change at Gruen zone 7. 
In order to do this we need to mimic their experimental 
data with “mock data” for both x and y variables as per Alm’s 
Figure 4. From inspection of that figure, the x-axis T-scores 
appear to have a mean of around -1.5 and a standard devia-
tion (SD) of 1. From this information, it is possible to pro-
duce a set of 39 random numbers normally distributed with 
this mean and SD using, for example, the “Data Analysis” 
toolkit in Microsoft Excel. This gives us our x variable. The y 
variable is comprised of a numerator showing the BMD dif-
ference between Gruen zone 7 BMD at 2 years and that at a 
preoperative baseline. From Alm et al’s data in Table 2, there 
is an average Gruen zone 7 BMD loss of -0.25 g/cm2 over 2 
years. We make the assumption that this is fixed at that value 
for all patients, i.e. no possibility of variation with systemic 
bone mineral status. The denominator of the y variable is the 
baseline Gruen zone 7 BMD expressed in g/cm2. From our 
own data on 26 adult females scheduled for THA, we obtain 
a  regression  equation  for  the  excellent  positive  correlation 
of baseline Gruen zone 7 BMD against baseline Total Hip 
T-score as expressed below:
Baseline Gruen zone 7 BMD = 1.51 + (0.1728 × Baseline 
Total Hip T-score)  (n = 26, r2 = 0.735, p < 0.0001)
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It is reasonable to accept this equation to an estimator for 
baseline Gruen zone 7 BMD given that Total Hip T-score is 
accepted as the most relevant indicator of systemic bone loss.
Therefore,  we  have  constructed  mock  data  for  both  the 
numerator and denominator of the y variable and can therefore 
combine these to provide “mock data” for the y variable. We 
now have a y variable incorporating a constant BMD change 
in Gruen zone 7. If we proceed to look for a “relation” between 
these “mock” x and y variables, we find that there is a strong 
positive correlation with the following regression equation:
Change in BMD (%) at Gruen zone 7 = –14 + (3.95 × Total 
Hip T-score)    (n = 39, r2 = 0.990, p < 0.0001)
From inspection of Alm et al’s Figure 4, the y-intercept 
is approximately -14 and the gradient is approximately 5.4. 
Therefore, our mock data gives similar results to the experi-
mental data of Alm et al. This occurs despite our choosing 
a constant BMD change in Gruen zone 7 at 2 years postop-
eratively, i.e. a change that was independent of systemic bone 
mineral status. The reason we get a “false”positive correla-
tion with our data is that the y variable denominator and the 
x variable, both of which are preoperative assessments, are 
highly correlated, i.e. a low Total Hip T-score corresponds to a 
low Gruen Zone 7 baseline BMD and because this appears on 
the denominator of the y variable, it increases the apparent % 
bone loss represented by that variable.
This analysis suggests that the conclusions made by Alm 
et al on the basis of their Figure 4 must be viewed with some 
caution. However, perhaps the most clinically important mes-
sage from their study is that if you start with poor quality 
bone at the femoral prosthesis, any further postoperative loss 
whether related to systemic bone mineral status or not will not 
improve the situation.
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Sir—We  appreciate  the  concern  posted  by  Drs.  Watson, 
Periasamy and Meek considering the regression curve pre-
sented in our paper (Alm et al. 2009). We agree that it is impor-
tant to be cautious when making conclusions from regression 
analyses because of the risk of false positive results. Here we 
present some points that verify our results and conclusions.
The main result and also the clinical message from our study 
was that systemic BMD predicts periprosthetic bone loss in 
Gruen zone 7, while other parameters (such as the local BMD 
of the hip) do not. This conclusion was made from the results 
presented in the line graph of Figure 3, where the patients 
were divided into three groups based on the systemic BMD 
(not the local BMD). We concluded from the results of this 
figure that “low preoperative systemic BMD was associated 
with higher bone loss in Gruen zone 7” since patients with 
systemic osteopenia or osteoporosis showed greater bone loss 
in this zone compared to patients with normal systemic BMD. 
We did not draw the conclusion based on the regression analy-
sis presented in Figure 4. In fact, this figure was added as a 
request of a reviewer during the review process of the journal. 
As posted by Watson and coauthors, it is possible to get a 
false positive correlation if the y variable denominator and 
the x variable are correlated. We would like to emphasize that 
the x variable used in Figure 4 was not the preoperative total 
hip T-score, but the lowest T-score recorded from all 10 areas 
measured for each patient, and in none of the 39 patients the 
lowest T-score was from the OA affected hip. Therefore, we 
did not have the problem caused by an expected high correla-
tion between the total hip T-score and denominator of the y 
variable, i.e., the baseline BMD of Gruen zone 7. 
What makes our results even more interesting is that when 
looking  at  the  local  BMD,  i.e.,  the  total  hip T-scores,  the 
values were high; only 6 of the osteopenic patients and one 
of the osteoporotic patients had osteopenic T-scores (between 
-1 and -2.5) at their affected hip. All other 32 patients had 
normal total hip T-scores. Still we found a significant associa-
tion between the percentage change in BMD of Gruen zone 7 
and the lowest systemic (not total hip) T-score. We can also 
add that the total hip T-scores did not correlate with the BMD-
changes in Gruen zone 7 at 24 months. 
Based on these results and those presented in our previous 
paper (Mäkinen et al. 2007), we disagree with Watson and 
Periasamy regarding local total hip T-score as the most repre-
sentative for systemic bone loss. On the contrary, one of our 
main observations was that DXA measurement of the local 
BMD of the affected hip is not representative for systemic 
bone loss or a predictor for periprosthetic bone loss. Osteoar-
thritis of the hip joint seems to increase “artificially” the local 
BMD. A recent study (Lingard et al. 2010) also confirmed that 
the diagnosis of osteoporosis may be missed in patients await-
ing  total  joint  replacement  unless  BMD  measurements  are 
performed at sites distant from the joint affected by OA (such 
as non-dominant forearm). 
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